Clinical Validation of Multimodal Digestive Endoscopy
Key facts
- Who runs it
- Xijing Hospital of Digestive Diseases
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Suspended
- People taking part
- 20 people, planned
- Started
- 11 Nov 2022
- Ended
- 10 Apr 2025
- Type of study
- Observational
- Record updated
- 2 April 2025
- Why it stopped
- At present, this exploratory study has preliminarily achieved the set goals, and the subsequent data analysis is currently underway to determine whether it is necessary to continue recruiting participants.
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age >18 years old
- Clinical diagnosis of colorectal cancer, colorectal polyps, colorectal adenomas and enteritis
- No allergy to relevant imaging agents
- Person who is able to understand and sign the informed consent form
- Person who is willing to participate in this experiment
Who cannot take part
- Patient who has been treated for colorectal lesions (endoscopic treatment, surgery , targeted therapy, and radiotherapy, etc.)
- Patients with severe, progressive, or uncontrolled diseases of the kidneys, liver, blood, gastrointestinal tract, endocrine system, lungs, heart, or nervous system
- Women who are pregnant or breastfeeding
- Person without personal freedom and independent civil capacity
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
According to the latest global cancer epidemiological data published by the International Agency for Research on Cancer, colorectal cancer (CRC) ranks 3rd in total incidence and 2nd in total mortality among all malignancies worldwide. The prognosis of CRC is directly related to tumor stage. The 5-year survival rate for early CRC can reach 90%, while less than 14% for advanced CRC. Therefore, early diagnosis of CRC is particularly important. Gastrointestinal (GI) endoscopy is an important method in the diagnosis of CRC. Currently, diagnosis of GI endoscopy is mainly based on morphological changes of tumors, while early-stage tumors are difficult to be detected because of the indistinguishable morphology. Studies have shown that the molecular function of cancer cells can be altered in early-stage tumors. The development of a new endoscopic system that can identify early tumor molecular function changes and improve the accuracy of morphological diagnosis will greatly improve the early diagnosis rate of CRC, which is the future direction of GI endoscopic system design and development.
Read full original descriptionShow less
The combination of high-definition white light endoscopy, endoscopic cerenkov luminescence imaging (ECLI) and probe-based confocal laser endomicroscopy (pCLE) is ideal for future new GI endoscopy. High-definition white light endoscopy is helpful to quickly find and locate suspected abnormal mucosa; on top of this, ECLI enables molecule-specific functional imaging for accurate identification and determination of GI lesions; and further relies on pCLE for high-precision "cellular-level" lesion images for optical biopsy of lesions. Through the multimodal digestive endoscopy, structural imaging and functional imaging can be accomplished simultaneously, playing the innate advantage of multimodal information fusion diagnosis and facilitating the identification of early-stage tumors.
In this clinical trial, patients with colorectal lesions who underwent PET-CT in Xijing Hospital were enrolled. Multimodal digestive endoscopy, combination of high-definition white light endoscopy, ECLI and pCLE, was used to perform for each patient's colorectal lesion. ECLI images were compared with PET-CT images, and pCLE images were compared with lesion histopathology, which evaluate the actual imaging effect of multimodal digestive endoscopy in human.
The group in the trial
- Patients with a clinical diagnosis of colorectal cancer, colorectal polyps, and colorectal adenomas
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Validation of Multimodal Digestive Endoscopy in the Diagnosis of Colorectal Lesions
- Publications
- Record updated
- 2 April 2025